About
Occuity is a UK-based medical technology company founded in 2019, focused on developing non-contact, handheld optical devices for chronic health challenges like diabetes, myopia, and Alzheimer's disease. The company aims to enhance screening and monitoring through innovative eye-based diagnostics that are non-invasive, pain-free, and consumable-free. Their product lineup includes ophthalmic devices such as the PM1 pachymeter for measuring corneal thickness, currently in clinical trials, and the AX1 axial length meter for myopia screening, set to launch in mid-2024. Occuity is also working on a non-contact blood glucose monitor for diabetes management, targeted for release in 2025. The company employs advanced optical techniques to provide rapid and accurate ocular measurements, revealing systemic health conditions. Occuity targets significant healthcare markets, including ophthalmology clinics and diabetes care providers, with devices designed for both clinical and personal use. The company has received recognition for its innovative instruments and is experiencing rapid growth, with plans for continued development and market expansion.
Technologies
Keywords
Company Information
-
Employees 38
-
Founded 2019
-
Total Funding $8425382
Location
Abbey Square, Reading, England, United Kingdom, RG1 3BE
